Abivax S.A. (ABVX)
NASDAQ·Healthcare·Biotechnology
$99.35
+1.00%
Mkt Cap $7.19B
Analyst Ratings
No recent rating data.
Price Target (17 analysts)
$145.67
Range $110.00 – $176.00
Implied Upside
+46.6%
Consensus $145.67 vs current $99.35
NASDAQ·Healthcare·Biotechnology
$99.35
+1.00%
Mkt Cap $7.19B
No recent rating data.
Price Target (17 analysts)
$145.67
Range $110.00 – $176.00
+46.6%
Consensus $145.67 vs current $99.35